Global Breakthrough Therapy (BT) Designation Market Insights and Forecast to 2028

Report ID: 1750073 | Published Date: Jan 2025 | No. of Page: 129 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Breakthrough Therapy (BT) Designation Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Oncology
        1.2.3 Infectious Diseases
        1.2.4 Rare Diseases
        1.2.5 Autoimmune Diseases
        1.2.6 Pulmonary Diseases
        1.2.7 Neurological Disorders
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Breakthrough Therapy (BT) Designation Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Research Institute
        1.3.5 Laboratories
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Breakthrough Therapy (BT) Designation Market Perspective (2017-2028)
    2.2 Breakthrough Therapy (BT) Designation Growth Trends by Region
        2.2.1 Breakthrough Therapy (BT) Designation Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Breakthrough Therapy (BT) Designation Historic Market Size by Region (2017-2022)
        2.2.3 Breakthrough Therapy (BT) Designation Forecasted Market Size by Region (2023-2028)
    2.3 Breakthrough Therapy (BT) Designation Market Dynamics
        2.3.1 Breakthrough Therapy (BT) Designation Industry Trends
        2.3.2 Breakthrough Therapy (BT) Designation Market Drivers
        2.3.3 Breakthrough Therapy (BT) Designation Market Challenges
        2.3.4 Breakthrough Therapy (BT) Designation Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Breakthrough Therapy (BT) Designation Players by Revenue
        3.1.1 Global Top Breakthrough Therapy (BT) Designation Players by Revenue (2017-2022)
        3.1.2 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Players (2017-2022)
    3.2 Global Breakthrough Therapy (BT) Designation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Breakthrough Therapy (BT) Designation Revenue
    3.4 Global Breakthrough Therapy (BT) Designation Market Concentration Ratio
        3.4.1 Global Breakthrough Therapy (BT) Designation Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Breakthrough Therapy (BT) Designation Revenue in 2021
    3.5 Breakthrough Therapy (BT) Designation Key Players Head office and Area Served
    3.6 Key Players Breakthrough Therapy (BT) Designation Product Solution and Service
    3.7 Date of Enter into Breakthrough Therapy (BT) Designation Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Breakthrough Therapy (BT) Designation Breakdown Data by Type
    4.1 Global Breakthrough Therapy (BT) Designation Historic Market Size by Type (2017-2022)
    4.2 Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Type (2023-2028)
5 Breakthrough Therapy (BT) Designation Breakdown Data by Application
    5.1 Global Breakthrough Therapy (BT) Designation Historic Market Size by Application (2017-2022)
    5.2 Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Breakthrough Therapy (BT) Designation Market Size (2017-2028)
    6.2 North America Breakthrough Therapy (BT) Designation Market Size by Type
        6.2.1 North America Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022)
        6.2.2 North America Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028)
        6.2.3 North America Breakthrough Therapy (BT) Designation Market Share by Type (2017-2028)
    6.3 North America Breakthrough Therapy (BT) Designation Market Size by Application
        6.3.1 North America Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022)
        6.3.2 North America Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028)
        6.3.3 North America Breakthrough Therapy (BT) Designation Market Share by Application (2017-2028)
    6.4 North America Breakthrough Therapy (BT) Designation Market Size by Country
        6.4.1 North America Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022)
        6.4.2 North America Breakthrough Therapy (BT) Designation Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Breakthrough Therapy (BT) Designation Market Size (2017-2028)
    7.2 Europe Breakthrough Therapy (BT) Designation Market Size by Type
        7.2.1 Europe Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022)
        7.2.2 Europe Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028)
        7.2.3 Europe Breakthrough Therapy (BT) Designation Market Share by Type (2017-2028)
    7.3 Europe Breakthrough Therapy (BT) Designation Market Size by Application
        7.3.1 Europe Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022)
        7.3.2 Europe Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028)
        7.3.3 Europe Breakthrough Therapy (BT) Designation Market Share by Application (2017-2028)
    7.4 Europe Breakthrough Therapy (BT) Designation Market Size by Country
        7.4.1 Europe Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022)
        7.4.2 Europe Breakthrough Therapy (BT) Designation Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size (2017-2028)
    8.2 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Type
        8.2.1 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Breakthrough Therapy (BT) Designation Market Share by Type (2017-2028)
    8.3 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Application
        8.3.1 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Breakthrough Therapy (BT) Designation Market Share by Application (2017-2028)
    8.4 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Region
        8.4.1 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Breakthrough Therapy (BT) Designation Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Breakthrough Therapy (BT) Designation Market Size (2017-2028)
    9.2 Latin America Breakthrough Therapy (BT) Designation Market Size by Type
        9.2.1 Latin America Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022)
        9.2.2 Latin America Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028)
        9.2.3 Latin America Breakthrough Therapy (BT) Designation Market Share by Type (2017-2028)
    9.3 Latin America Breakthrough Therapy (BT) Designation Market Size by Application
        9.3.1 Latin America Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022)
        9.3.2 Latin America Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028)
        9.3.3 Latin America Breakthrough Therapy (BT) Designation Market Share by Application (2017-2028)
    9.4 Latin America Breakthrough Therapy (BT) Designation Market Size by Country
        9.4.1 Latin America Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022)
        9.4.2 Latin America Breakthrough Therapy (BT) Designation Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size (2017-2028)
    10.2 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Type
        10.2.1 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Breakthrough Therapy (BT) Designation Market Share by Type (2017-2028)
    10.3 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Application
        10.3.1 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Breakthrough Therapy (BT) Designation Market Share by Application (2017-2028)
    10.4 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Country
        10.4.1 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Breakthrough Therapy (BT) Designation Introduction
        11.1.4 Roche Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Abbvie
        11.2.1 Abbvie Company Details
        11.2.2 Abbvie Business Overview
        11.2.3 Abbvie Breakthrough Therapy (BT) Designation Introduction
        11.2.4 Abbvie Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.2.5 Abbvie Recent Developments
    11.3 Novartis International AG
        11.3.1 Novartis International AG Company Details
        11.3.2 Novartis International AG Business Overview
        11.3.3 Novartis International AG Breakthrough Therapy (BT) Designation Introduction
        11.3.4 Novartis International AG Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.3.5 Novartis International AG Recent Developments
    11.4 Janssen
        11.4.1 Janssen Company Details
        11.4.2 Janssen Business Overview
        11.4.3 Janssen Breakthrough Therapy (BT) Designation Introduction
        11.4.4 Janssen Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.4.5 Janssen Recent Developments
    11.5 BMS
        11.5.1 BMS Company Details
        11.5.2 BMS Business Overview
        11.5.3 BMS Breakthrough Therapy (BT) Designation Introduction
        11.5.4 BMS Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.5.5 BMS Recent Developments
    11.6 Eli Lilly
        11.6.1 Eli Lilly Company Details
        11.6.2 Eli Lilly Business Overview
        11.6.3 Eli Lilly Breakthrough Therapy (BT) Designation Introduction
        11.6.4 Eli Lilly Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.6.5 Eli Lilly Recent Developments
    11.7 Gilead
        11.7.1 Gilead Company Details
        11.7.2 Gilead Business Overview
        11.7.3 Gilead Breakthrough Therapy (BT) Designation Introduction
        11.7.4 Gilead Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.7.5 Gilead Recent Developments
    11.8 Sanofi
        11.8.1 Sanofi Company Details
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Breakthrough Therapy (BT) Designation Introduction
        11.8.4 Sanofi Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.8.5 Sanofi Recent Developments
    11.9 Regeneron
        11.9.1 Regeneron Company Details
        11.9.2 Regeneron Business Overview
        11.9.3 Regeneron Breakthrough Therapy (BT) Designation Introduction
        11.9.4 Regeneron Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.9.5 Regeneron Recent Developments
    11.10 Acadia
        11.10.1 Acadia Company Details
        11.10.2 Acadia Business Overview
        11.10.3 Acadia Breakthrough Therapy (BT) Designation Introduction
        11.10.4 Acadia Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.10.5 Acadia Recent Developments
    11.11 Boehringer Ingelheim
        11.11.1 Boehringer Ingelheim Company Details
        11.11.2 Boehringer Ingelheim Business Overview
        11.11.3 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Introduction
        11.11.4 Boehringer Ingelheim Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.11.5 Boehringer Ingelheim Recent Developments
    11.12 Amgen
        11.12.1 Amgen Company Details
        11.12.2 Amgen Business Overview
        11.12.3 Amgen Breakthrough Therapy (BT) Designation Introduction
        11.12.4 Amgen Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.12.5 Amgen Recent Developments
    11.13 AstraZeneca
        11.13.1 AstraZeneca Company Details
        11.13.2 AstraZeneca Business Overview
        11.13.3 AstraZeneca Breakthrough Therapy (BT) Designation Introduction
        11.13.4 AstraZeneca Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.13.5 AstraZeneca Recent Developments
    11.14 GlaxoSmithKline
        11.14.1 GlaxoSmithKline Company Details
        11.14.2 GlaxoSmithKline Business Overview
        11.14.3 GlaxoSmithKline Breakthrough Therapy (BT) Designation Introduction
        11.14.4 GlaxoSmithKline Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.14.5 GlaxoSmithKline Recent Developments
    11.15 Vertex
        11.15.1 Vertex Company Details
        11.15.2 Vertex Business Overview
        11.15.3 Vertex Breakthrough Therapy (BT) Designation Introduction
        11.15.4 Vertex Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.15.5 Vertex Recent Developments
    11.16 Alexion
        11.16.1 Alexion Company Details
        11.16.2 Alexion Business Overview
        11.16.3 Alexion Breakthrough Therapy (BT) Designation Introduction
        11.16.4 Alexion Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.16.5 Alexion Recent Developments
    11.17 Merck
        11.17.1 Merck Company Details
        11.17.2 Merck Business Overview
        11.17.3 Merck Breakthrough Therapy (BT) Designation Introduction
        11.17.4 Merck Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.17.5 Merck Recent Developments
    11.18 Jazz Pharmaceuticals
        11.18.1 Jazz Pharmaceuticals Company Details
        11.18.2 Jazz Pharmaceuticals Business Overview
        11.18.3 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Introduction
        11.18.4 Jazz Pharmaceuticals Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.18.5 Jazz Pharmaceuticals Recent Developments
    11.19 Exelixis
        11.19.1 Exelixis Company Details
        11.19.2 Exelixis Business Overview
        11.19.3 Exelixis Breakthrough Therapy (BT) Designation Introduction
        11.19.4 Exelixis Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.19.5 Exelixis Recent Developments
    11.20 Eisai
        11.20.1 Eisai Company Details
        11.20.2 Eisai Business Overview
        11.20.3 Eisai Breakthrough Therapy (BT) Designation Introduction
        11.20.4 Eisai Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.20.5 Eisai Recent Developments
    11.21 Takeda
        11.21.1 Takeda Company Details
        11.21.2 Takeda Business Overview
        11.21.3 Takeda Breakthrough Therapy (BT) Designation Introduction
        11.21.4 Takeda Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.21.5 Takeda Recent Developments
    11.22 Pfizer
        11.22.1 Pfizer Company Details
        11.22.2 Pfizer Business Overview
        11.22.3 Pfizer Breakthrough Therapy (BT) Designation Introduction
        11.22.4 Pfizer Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022)
        11.22.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Breakthrough Therapy (BT) Designation Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Oncology
    Table 3. Key Players of Infectious Diseases
    Table 4. Key Players of Rare Diseases
    Table 5. Key Players of Autoimmune Diseases
    Table 6. Key Players of Pulmonary Diseases
    Table 7. Key Players of Neurological Disorders
    Table 8. Key Players of Others
    Table 9. Global Breakthrough Therapy (BT) Designation Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global Breakthrough Therapy (BT) Designation Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global Breakthrough Therapy (BT) Designation Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global Breakthrough Therapy (BT) Designation Market Share by Region (2017-2022)
    Table 13. Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global Breakthrough Therapy (BT) Designation Market Share by Region (2023-2028)
    Table 15. Breakthrough Therapy (BT) Designation Market Trends
    Table 16. Breakthrough Therapy (BT) Designation Market Drivers
    Table 17. Breakthrough Therapy (BT) Designation Market Challenges
    Table 18. Breakthrough Therapy (BT) Designation Market Restraints
    Table 19. Global Breakthrough Therapy (BT) Designation Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global Breakthrough Therapy (BT) Designation Revenue Share by Players (2017-2022)
    Table 21. Global Top Breakthrough Therapy (BT) Designation by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breakthrough Therapy (BT) Designation as of 2021)
    Table 22. Ranking of Global Top Breakthrough Therapy (BT) Designation Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by Breakthrough Therapy (BT) Designation Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Breakthrough Therapy (BT) Designation Product Solution and Service
    Table 26. Date of Enter into Breakthrough Therapy (BT) Designation Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type (2017-2022)
    Table 30. Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type (2023-2028)
    Table 32. Global Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global Breakthrough Therapy (BT) Designation Revenue Share by Application (2017-2022)
    Table 34. Global Breakthrough Therapy (BT) Designation Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global Breakthrough Therapy (BT) Designation Revenue Share by Application (2023-2028)
    Table 36. North America Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America Breakthrough Therapy (BT) Designation Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe Breakthrough Therapy (BT) Designation Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific Breakthrough Therapy (BT) Designation Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific Breakthrough Therapy (BT) Designation Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America Breakthrough Therapy (BT) Designation Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Breakthrough Therapy (BT) Designation Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Breakthrough Therapy (BT) Designation Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa Breakthrough Therapy (BT) Designation Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Roche Company Details
    Table 67. Roche Business Overview
    Table 68. Roche Breakthrough Therapy (BT) Designation Product
    Table 69. Roche Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 70. Roche Recent Developments
    Table 71. Abbvie Company Details
    Table 72. Abbvie Business Overview
    Table 73. Abbvie Breakthrough Therapy (BT) Designation Product
    Table 74. Abbvie Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 75. Abbvie Recent Developments
    Table 76. Novartis International AG Company Details
    Table 77. Novartis International AG Business Overview
    Table 78. Novartis International AG Breakthrough Therapy (BT) Designation Product
    Table 79. Novartis International AG Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 80. Novartis International AG Recent Developments
    Table 81. Janssen Company Details
    Table 82. Janssen Business Overview
    Table 83. Janssen Breakthrough Therapy (BT) Designation Product
    Table 84. Janssen Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 85. Janssen Recent Developments
    Table 86. BMS Company Details
    Table 87. BMS Business Overview
    Table 88. BMS Breakthrough Therapy (BT) Designation Product
    Table 89. BMS Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 90. BMS Recent Developments
    Table 91. Eli Lilly Company Details
    Table 92. Eli Lilly Business Overview
    Table 93. Eli Lilly Breakthrough Therapy (BT) Designation Product
    Table 94. Eli Lilly Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 95. Eli Lilly Recent Developments
    Table 96. Gilead Company Details
    Table 97. Gilead Business Overview
    Table 98. Gilead Breakthrough Therapy (BT) Designation Product
    Table 99. Gilead Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 100. Gilead Recent Developments
    Table 101. Sanofi Company Details
    Table 102. Sanofi Business Overview
    Table 103. Sanofi Breakthrough Therapy (BT) Designation Product
    Table 104. Sanofi Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 105. Sanofi Recent Developments
    Table 106. Regeneron Company Details
    Table 107. Regeneron Business Overview
    Table 108. Regeneron Breakthrough Therapy (BT) Designation Product
    Table 109. Regeneron Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 110. Regeneron Recent Developments
    Table 111. Acadia Company Details
    Table 112. Acadia Business Overview
    Table 113. Acadia Breakthrough Therapy (BT) Designation Product
    Table 114. Acadia Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 115. Acadia Recent Developments
    Table 116. Boehringer Ingelheim Company Details
    Table 117. Boehringer Ingelheim Business Overview
    Table 118. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Product
    Table 119. Boehringer Ingelheim Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 120. Boehringer Ingelheim Recent Developments
    Table 121. Amgen Company Details
    Table 122. Amgen Business Overview
    Table 123. Amgen Breakthrough Therapy (BT) Designation Product
    Table 124. Amgen Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 125. Amgen Recent Developments
    Table 126. AstraZeneca Company Details
    Table 127. AstraZeneca Business Overview
    Table 128. AstraZeneca Breakthrough Therapy (BT) Designation Product
    Table 129. AstraZeneca Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 130. AstraZeneca Recent Developments
    Table 131. GlaxoSmithKline Company Details
    Table 132. GlaxoSmithKline Business Overview
    Table 133. GlaxoSmithKline Breakthrough Therapy (BT) Designation Product
    Table 134. GlaxoSmithKline Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 135. GlaxoSmithKline Recent Developments
    Table 136. Vertex Company Details
    Table 137. Vertex Business Overview
    Table 138. Vertex Breakthrough Therapy (BT) Designation Product
    Table 139. Vertex Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 140. Vertex Recent Developments
    Table 141. Alexion Company Details
    Table 142. Alexion Business Overview
    Table 143. Alexion Breakthrough Therapy (BT) Designation Product
    Table 144. Alexion Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 145. Alexion Recent Developments
    Table 146. Merck Company Details
    Table 147. Merck Business Overview
    Table 148. Merck Breakthrough Therapy (BT) Designation Product
    Table 149. Merck Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 150. Merck Recent Developments
    Table 151. Jazz Pharmaceuticals Company Details
    Table 152. Jazz Pharmaceuticals Business Overview
    Table 153. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Product
    Table 154. Jazz Pharmaceuticals Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 155. Jazz Pharmaceuticals Recent Developments
    Table 156. Exelixis Company Details
    Table 157. Exelixis Business Overview
    Table 158. Exelixis Breakthrough Therapy (BT) Designation Product
    Table 159. Exelixis Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 160. Exelixis Recent Developments
    Table 161. Eisai Company Details
    Table 162. Eisai Business Overview
    Table 163. Eisai Breakthrough Therapy (BT) Designation Product
    Table 164. Eisai Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 165. Eisai Recent Developments
    Table 166. Takeda Company Details
    Table 167. Takeda Business Overview
    Table 168. Takeda Breakthrough Therapy (BT) Designation Product
    Table 169. Takeda Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 170. Takeda Recent Developments
    Table 171. Pfizer Company Details
    Table 172. Pfizer Business Overview
    Table 173. Pfizer Breakthrough Therapy (BT) Designation Product
    Table 174. Pfizer Revenue in Breakthrough Therapy (BT) Designation Business (2017-2022) & (US$ Million)
    Table 175. Pfizer Recent Developments
    Table 176. Research Programs/Design for This Report
    Table 177. Key Data Information from Secondary Sources
    Table 178. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Breakthrough Therapy (BT) Designation Market Share by Type: 2021 VS 2028
    Figure 2. Oncology Features
    Figure 3. Infectious Diseases Features
    Figure 4. Rare Diseases Features
    Figure 5. Autoimmune Diseases Features
    Figure 6. Pulmonary Diseases Features
    Figure 7. Neurological Disorders Features
    Figure 8. Others Features
    Figure 9. Global Breakthrough Therapy (BT) Designation Market Share by Application: 2021 VS 2028
    Figure 10. Hospital Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Research Institute Case Studies
    Figure 13. Laboratories Case Studies
    Figure 14. Others Case Studies
    Figure 15. Breakthrough Therapy (BT) Designation Report Years Considered
    Figure 16. Global Breakthrough Therapy (BT) Designation Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 17. Global Breakthrough Therapy (BT) Designation Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 18. Global Breakthrough Therapy (BT) Designation Market Share by Region: 2021 VS 2028
    Figure 19. Global Breakthrough Therapy (BT) Designation Market Share by Players in 2021
    Figure 20. Global Top Breakthrough Therapy (BT) Designation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breakthrough Therapy (BT) Designation as of 2021)
    Figure 21. The Top 10 and 5 Players Market Share by Breakthrough Therapy (BT) Designation Revenue in 2021
    Figure 22. North America Breakthrough Therapy (BT) Designation Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. North America Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2028)
    Figure 24. North America Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2028)
    Figure 25. North America Breakthrough Therapy (BT) Designation Market Size Share by Country (2017-2028)
    Figure 26. United States Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Canada Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Europe Breakthrough Therapy (BT) Designation Market Size YoY (2017-2028) & (US$ Million)
    Figure 29. Europe Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2028)
    Figure 30. Europe Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2028)
    Figure 31. Europe Breakthrough Therapy (BT) Designation Market Size Share by Country (2017-2028)
    Figure 32. Germany Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. France Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. U.K. Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Italy Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Russia Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Nordic Countries Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Breakthrough Therapy (BT) Designation Market Size YoY (2017-2028) & (US$ Million)
    Figure 39. Asia Pacific Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2028)
    Figure 40. Asia Pacific Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2028)
    Figure 41. Asia Pacific Breakthrough Therapy (BT) Designation Market Size Share by Region (2017-2028)
    Figure 42. China Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Japan Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. South Korea Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Southeast Asia Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. India Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Australia Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 48. Latin America Breakthrough Therapy (BT) Designation Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Latin America Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2028)
    Figure 50. Latin America Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2028)
    Figure 51. Latin America Breakthrough Therapy (BT) Designation Market Size Share by Country (2017-2028)
    Figure 52. Mexico Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Brazil Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size YoY (2017-2028) & (US$ Million)
    Figure 55. Middle East and Africa Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2028)
    Figure 56. Middle East and Africa Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2028)
    Figure 57. Middle East and Africa Breakthrough Therapy (BT) Designation Market Size Share by Country (2017-2028)
    Figure 58. Turkey Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. Saudi Arabia Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. UAE Breakthrough Therapy (BT) Designation Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 61. Roche Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 62. Abbvie Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 63. Novartis International AG Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 64. Janssen Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 65. BMS Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 66. Eli Lilly Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 67. Gilead Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 68. Sanofi Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 69. Regeneron Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 70. Acadia Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 71. Boehringer Ingelheim Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 72. Amgen Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 73. AstraZeneca Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 74. GlaxoSmithKline Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 75. Vertex Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 76. Alexion Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 77. Merck Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 78. Jazz Pharmaceuticals Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 79. Exelixis Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 80. Eisai Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 81. Takeda Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 82. Pfizer Revenue Growth Rate in Breakthrough Therapy (BT) Designation Business (2017-2022)
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche
Abbvie
Novartis International AG
Janssen
BMS
Eli Lilly
Gilead
Sanofi
Regeneron
Acadia
Boehringer Ingelheim
Amgen
AstraZeneca
GlaxoSmithKline
Vertex
Alexion
Merck
Jazz Pharmaceuticals
Exelixis
Eisai
Takeda
Pfizer
Frequently Asked Questions
Breakthrough Therapy (BT) Designation report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Breakthrough Therapy (BT) Designation report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Breakthrough Therapy (BT) Designation report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Books

Books market is segmented by Type and by Application. Players, stakeholders, and other participan ... Read More

Packaged Water

Packaged Water market is segmented by Type and by Application. Players, stakeholders, and other p ... Read More